Back

Predictability of noninvasive liver fibrosis score for cardiac events in patients with nonalcoholic fatty liver disease

26 August 2023 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Imaging in autoimmune disease Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Naoki Shibata

Ogaki Municipal Hospital, Ogaki (Japan)

8 More presentations in this session

Presentation thumbnail
Ventriculoarterial coupling as estimated by the PWV/GLS ratio correlates with disease severity in liver cirrhosis patients
Doctor I. Dimitroglou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Longitudinal myocardial deformation and its improvement after treatment has an additive prognostic value to SCORE2 in psoriasis: a 4-year follow-up study
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Angio-IMR identifies microvascular cardiac allograft vasculopathy in heart transplant recipients
Doctor K. Weiss (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Reduced left ventricular elastance as a novel marker of cardiac dysfunction in patients with severe liver disease
Doctor I. Dimitroglou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Fully automated quantitative stress perfusion cardiac MRI to assess myocardial perfusion in adult patients with convalescent Kawasaki disease and coronary aneurysms: an age and sex-matched analysis
Doctor K. Cheng (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Imaging in autoimmune disease

The Event

Event poster

ESC Congress 2023

26 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
A direct comparison of non-invasive blood markers of liver fibrosis as associates of cardiovascular risk. The Athens cardiometabolic registry
thumbnail
Congress Presentation
Liver fibrosis and poor outcome in patients with heart failure: new insights from the BIOSTAT-CHF study
thumbnail
Congress Presentation
Clinical utility of the FIB-4 index for predicting cardiovascular outcomes in patients with metabolic dysfunction-associated steatotic liver disease: a 10-year retrospective cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources